Retractable Technologies Inc (RVP)
1.07
+0.01
(+0.94%)
USD |
NYAM |
Apr 26, 16:00
1.07
0.00 (0.00%)
After-Hours: 20:00
Retractable Technologies Enterprise Value: -13.79M for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 25, 2024 | -13.79M |
April 24, 2024 | -13.19M |
April 23, 2024 | -13.49M |
April 22, 2024 | -13.49M |
April 19, 2024 | -13.79M |
April 18, 2024 | -14.09M |
April 17, 2024 | -14.39M |
April 16, 2024 | -13.49M |
April 15, 2024 | -13.79M |
April 12, 2024 | -13.19M |
April 11, 2024 | -12.29M |
April 10, 2024 | -12.59M |
April 09, 2024 | -12.29M |
April 08, 2024 | -12.59M |
April 05, 2024 | -13.19M |
April 04, 2024 | -11.69M |
April 03, 2024 | -11.14M |
April 02, 2024 | -11.09M |
April 01, 2024 | -10.49M |
March 28, 2024 | -9.596M |
March 27, 2024 | -9.896M |
March 26, 2024 | -10.19M |
March 25, 2024 | -9.333M |
March 22, 2024 | -9.297M |
March 21, 2024 | -9.297M |
Date | Value |
---|---|
March 20, 2024 | -9.746M |
March 19, 2024 | -9.596M |
March 18, 2024 | -9.596M |
March 15, 2024 | -9.596M |
March 14, 2024 | -8.997M |
March 13, 2024 | -8.997M |
March 12, 2024 | -9.297M |
March 11, 2024 | -9.596M |
March 08, 2024 | -8.396M |
March 07, 2024 | -8.997M |
March 06, 2024 | -7.800M |
March 05, 2024 | -7.501M |
March 04, 2024 | -7.201M |
March 01, 2024 | -7.501M |
February 29, 2024 | -6.902M |
February 28, 2024 | -6.004M |
February 27, 2024 | -6.902M |
February 26, 2024 | -6.902M |
February 23, 2024 | -6.602M |
February 22, 2024 | -5.405M |
February 21, 2024 | -6.602M |
February 20, 2024 | -7.198M |
February 16, 2024 | -6.752M |
February 15, 2024 | -7.294M |
February 14, 2024 | -8.099M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-14.39M
Minimum
Apr 17 2024
708.44M
Maximum
Feb 01 2021
125.01M
Average
42.64M
Median
Jan 16 2020
Enterprise Value Benchmarks
Perspective Therapeutics Inc | 931.55M |
InfuSystems Holdings Inc | 190.69M |
Xtant Medical Holdings Inc | 133.46M |
Asensus Surgical Inc | 44.48M |
Catheter Precision Inc | 0.7844M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -0.0729M |
Revenue (Quarterly) | 14.29M |
Total Expenses (Quarterly) | 15.32M |
Gross Profit Margin (Quarterly) | 10.78% |
Profit Margin (Quarterly) | -0.51% |
Earnings Yield | -22.43% |
Normalized Earnings Yield | -10.80 |